Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment

BACKGROUND AND AIM: To investigate the risk of hepatitis B virus reactivation in patients undergoing long-term tocilizumab therapy for rheumatoid arthritis. METHOD: From January 2011 through August 2019, a total of 97 patients were enrolled in this retrospective study. Clinical data, comedications,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Meng Hsuan, Tseng, Chih-Wei, Lu, Ming-Chi, Tung, Chien-Hsueh, Tseng, Kuo-Chih, Huang, Kuang-Yung, Lee, Chi-Hui, Lai, Ning-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775841/
https://www.ncbi.nlm.nih.gov/pubmed/33387124
http://dx.doi.org/10.1007/s10620-020-06725-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775841/
https://www.ncbi.nlm.nih.gov/pubmed/33387124
http://dx.doi.org/10.1007/s10620-020-06725-1

Ejemplares similares